1 January 2024

No high-quality study with an appropriate design for assessing puberty-blocker outcomes was identified in that 2024 revi

Name: No high-quality study with an appropriate design for assessing puberty-blocker outcomes was identified in that 2024 revi
Start: 2024-01-01
Location: International

No high-quality study with an appropriate design for assessing puberty-blocker outcomes was identified in that 2024 review.

Source: Evidence review: Gonadotrophin releasing hormone analogues for children and adolescents with gender dysphoria (NICE/NHS England, 2020)

Jurisdiction: International

Read the dossier on this idea